Analyst Ratings for Quince Therapeutics Inc. (QNCX)

QNCX Rating Summary

  |   Expand Research on QNCX
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: N/A
Rating Score: 4.3 / 10   Percentile Rank: 43%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/30/2026 Maxim Group Jason McCarthy Downgrade Hold
(Buy)		 N/A
(N/A)		 0.27
(0.10)		 -62.96% Details
1/30/2026 Lucid Capital Markets Elemer Piros Downgrade Sell
(Buy)		 N/A
(8.00)		 0.27
(0.10)		 -62.96% Details